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Abstract
Neuropathic pain remains intractable and the development of new therapeutic strategies are urgently required.
Accumulating evidence indicates that overproduction of oxidative stress is a key event in the pathogenesis of neuropathic
pain. However, repeated intra-peritoneal or intrathecal injections of antioxidants are unsuitable for continuous use in
therapy. Here we show a novel therapeutic method against neuropathic pain: drinking water containing molecular
hydrogen (H2) as antioxidant. The effect of hydrogen on neuropathic pain was investigated using a partial sciatic nerve
ligation model in mice. As indicators of neuropathic pain, temporal aspects of mechanical allodynia and thermal
hyperalgesia were analysed for 3 weeks after ligation. Mechanical allodynia and thermal hyperalgesia were measured using
the von Frey test and the plantar test, respectively. When mice were allowed to drink water containing hydrogen at a
saturated level ad libitum after ligation, both allodynia and hyperalgesia were alleviated. These symptoms were also
alleviated when hydrogen was administered only for the induction phase (from day 0 to 4 after ligation). When hydrogen
was administered only for the maintenance phase (from day 4 to 21 after ligation), hyperalgesia but not allodynia was
alleviated. Immunohistochemical staining for the oxidative stress marker, 4-hydroxy-2-nonenal and 8-hydroxydeoxygua-
nosine, showed that hydrogen administration suppressed oxidative stress induced by ligation in the spinal cord and the
dorsal root ganglion. In conclusion, oral administration of hydrogen water may be useful for alleviating neuropathic pain in
a clinical setting.
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Introduction
Neuropathic pain is one of abnormal chronic pain that is
produced after trauma or disease of the peripheral or the central
nervous system. The common symptoms of neuropathic pain are
mechanical allodynia, a painful response to innocuous tactile
stimuli, and hyperalgesia, a decrease in nociceptive thresholds to
the stimuli. Neuropathic pain remains intractable and many
patients suffering from this disease exact a tremendous cost to the
economy. Anti-inflammatories including non-steroidal anti-inflam-
matory drug and some narcotic analgesics are not effective for
managing neuropathic pain and the need for higher dosages of
these drugs leads to unsatisfactory side effects. Therefore, the
development of new therapeutic strategies is urgently required.
Reactive oxygen species (ROS) are reported to be involved in
the pathomechanism of neuropathic pain [1–4]. Although the
mechanism by which excessive ROS produce pain is largely
unclear, antioxidants have received attention as novel analgesics
against neuropathic pain [3]. It was reported that systemic
administration of antioxidants produced an analgesic effect in
animal models of neuropathic pain. For instance, phenyl-N-tert-
butylnitrone (PBN), 5,5-dimethylpyrroline-N-oxide, vitamin E,
and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL)
could ameliorate the behavioral signs of neuropathic pain [5–8].
In these reports, analgesia was extended by repeated injections of
drugs at short intervals. Thus, if these agents are to be useful in
therapy, they will have to be given continuously or at relatively
short interval, which is unsuitable for clinical medication.
Molecular hydrogen has recently received attention as a novel
antioxidant with high efficacy and no currently known side effect
[9]. Because of its small size and electrically neutral properties,
molecular hydrogen can reach target organs easily. Drinking water
with dissolved hydrogen has been reported to be effective in
preventing oxidative stress in some animal models of other diseases
[10–12]. In addition, hydrogen does not accumulate in living cells
nor produce noxious metabolites, which sometimes cause distress
in other antioxidants.
ROS include hydroxyl radical, hydrogen peroxide, superoxide,
nitric oxide, and nitroperoxide. Among them, hydroxyl radical is
extremely toxic and has no currently known beneficial role.
Furthermore, no defense system against hydroxyl radical has been
found in mammalian cells. On the other hand, hydrogen peroxide,
superoxide, and nitric oxide have important roles in various
biological processes at low concentrations [13–15]. Thus, there is a
concern about continuous use of antioxidant that might cause
serious side effect. Hydrogen is a more attractive antioxidant, in
that unlike other antioxidants it can selectively neutralize the
hydroxyl radical, while having minimal effect on beneficial ROS
[9].
In the present study, we show that molecular hydrogen can
ameliorate mechanical allodynia and thermal hyperalgesia. Our
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results indicate that hydrogen administration by the oral pathway
may have potential for the management of neuropathic pain.
Materials and Methods
Ethics Statement
The care and use of all mice in this study was carried out in
accordance with institutional ethical guidelines for animal
experiments of the National Defense Medical College (Tokor-
ozawa, Saitama, Japan), and were approved by the Committee for
Animal Research at the National Defense Medical College.
Guidelines of the Committee for Research and Ethical Issues of
the International Association for the Study of Pain [16] was strictly
adhered to in this study.
Animals
We used C57BL/6 mice at 8-weeks old when subjected to nerve
ligation. These mice were maintained on a 12-h light–dark cycle
(lights on from 07:00 to 19:00) with room temperature at 2161uC.
They had access to water and food ad libitum.
Hydrogen Water
Hydrogen water was produced by Blue Mercury Inc. (Tokyo,
Japan), which contained more than 0.6 mM hydrogen. Hydrogen
water was put in an aluminium bottle (60 ml) to maintain the
concentration of hydrogen. Mice were allowed to drink hydrogen
water ad libitum for indicated time. Hydrogen water was exchanged
every day to keep the hydrogen concentration constant. Control
groups were supplied with distilled water. There was no significant
difference in the amounts of water consumed between hydrogen
group and control group (3.8760.13 vs. 3.9160.15 ml, mean 6
SEM, n= 12 mice for each). Amount of water consumed was
monitored by recording the volume of water in the bottle.
Mouse Study Design
Siblings from the same litter were randomly allocated into one
of the following groups so that each group was balanced on
littermate. Ligation group: n = 12, Ligation+hydrogen (day 0–21)
group: n = 12, Ligation+hydrogen (day 0–4) group: n= 12,
Ligation+hydrogen (day 4–21) group: n= 12, Sham group:
n = 12, Sham+hydrogen (day 0–21) group: n = 12.
Nerve Injury Pain Model
Throughout the experiment, we used a partial sciatic nerve
ligation (PSNL) model as a neuropathic pain model (Seltzer model)
as described previously [17]. Briefly, the sciatic nerve located in
the right hind paw was exposed via a small incision and
approximately 1/3–1/2 the diameter of the nerve was tightly
ligated with an 8–0 silk suture. PSNL caused a fast and
pronounced development of mechanical allodynia and thermal
hyperalgesia in mice. In the sham-operated groups, sciatic nerves
were exposed without ligation. The pain behaviors were assessed
by the von Frey test and the plantar test for mechanical allodynia
and thermal hyperalgesia, respectively. These behaviors were
tested before (Pre) and after PSNL operation (day 1, 4, 7, 14, and
21). Measurement was carried out by an investigator blinded to
the hydrogen treatment.
Measurement of Mechanical Allodynia
To quantify mechanical allodynia, paw withdrawal responses to
mechanical stimulation were assessed with von Frey filaments as
previously described [17]. Briefly, mice were habituated for at least
1 h prior to testing in a clear acrylic cylinder (20 cm in height and
10 cm in diameter) on an elevated mesh floor. Calibrated von Frey
filaments (North Coast Medical, Gilroy, CA) were then applied
through the mesh to the plantar surface on hind paw. Filaments
were applied for 1 s and this was repeated 5 times at a frequency
of 0.5 Hz. Filaments were pressed until the filament bent. Paw
movements associated with locomotion or weight shifting were not
counted as responses. The lightest filament of 0.008 g bending
force was initially applied with progressively increasing force (0.02,
0.04, 0.07, 0.16, 0.4, 0.6, 1.0, 1.4, and 2.0 g). Measurement was
finished when paw withdrawals were evoked at least three
withdrawals out of five applications, and the calibrated bending
force of the filament was defined as the paw withdrawal threshold.
Measurement of Thermal (Heat) Hyperalgesia
Response to thermal stimulation were measured as previously
described [18] with some modifications using a plantar test
apparatus (ANESTHESIA RESEARCH Lab, University of
California, San Diego, CA). The intensity of the thermal stimulus
was adjusted to achieve a baseline paw-withdrawal latency of
approximately 7–9 sec on average in naive mice. Paw withdrawal
latency was determined as the average of three scores per paw.
Immunohistochemical Studies
Immunohistochemical study on the dorsal root ganglion (DRG)
and the spinal cord of at the lumbar level was performed as
previously described [19]. Briefly, paraffin sections (5 mm thick)
were deparaffinized and immersed in unmasking solution (Vector
H3300; Vector Laboratories, Burlingame, CA) for antigenic
retrieval and heated in an autoclave (121uC) for 5 min. The
sections were then incubated in a nonspecific blocking reagent
(Dako, Glostrup, Denmark) for 30 min to reduce background
staining. Sections were then incubated with primary antibodies
overnight in a humidified chamber at 4uC. Primary antibodies
used in this study were anti-4-hydroxy-2-nonenal (4-HNE) (mouse
monoclonal, Japan Institute for the Control of Aging, Shizuoka,
Japan), anti-8-hydroxydeoxyguanosine (8-OHdG) (mouse mono-
clonal, Japan Institute for the Control of Aging), anti-neuronal
nuclear antigen (NeuN) (rabbit polyclonal, Millipore, Billerica,
MA), anti-glial fibrillary acidic protein (GFAP) (rabbit polyclonal,
Thermo Fisher Scientific, Waltham, MA), anti-NG2 (rabbit
polyclonal, Abcam, Cambridge, UK), anti-Olig2 (rabbit polyclon-
al, Abcam), and anti-Iba1 (rabbit polyclonal, Wako, Osaka, Japan)
antibodies.
For fluorescent staining, sections were incubated with Alexa-
Fluor 488-conjugated goat anti-rabbit IgG (1:200; Molecular
Probes, Eugene, OR) for primary antibodies derived from mouse.
For primary antibody derived from rabbit, Alexa-Fluor 546-
conjugated goat anti-mouse IgG (1:200; Molecular Probes) was
used. Sections were examined using a Nikon fluorescence
microscopy system (Nikon, Tokyo, Japan) with electron-multiply-
ing (EM) CCD digital camera (ImagEM, Hamamatsu Photonics,
Hamamatsu, Japan).
Samples from six slides (from six mice) per experimental
conditions were examined. For quantification of the spinal cord
sections, total number of positive cells for 4-HNE or 8OHdG was
counted. For quantification of the DRG sections, the proportion of
positive cells was determined by positive neuron profile divided by
the total neuronal profiles on each section. Counting of
immunostaining was performed by an investigator blinded to the
treatment conditions.
Statistics
Statistical analysis was performed using GraphPad Prism 5
(GraphPad Software Inc.). Comparisons of the means of each
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group were performed using a Student’s t test or two-way repeated
measures analysis of variance (two-way RM ANOVA) with a
Bonferroni post-hoc test. Details regarding specific statistical tests
are included in the results. Values are presented as the mean 6
SEM.
Results
Mechanical Allodynia and Hyperalgesia Induced by PSNL
was Alleviated by Hydrogen Water
To examine the effect of hydrogen water against neuropathic
pain, we tested whether ad libitum drinking of hydrogen water
modified mechanical allodynia and hyperalgesia in PSNL model
mice. In control mice (without hydrogen), PSNL caused a
significant and long-lasting decrease in their mechanical threshold
measured with von Frey hairs (Figure 1A). A two-way RM
ANOVA confirmed this, indicating a significant difference
between the ipsilateral and the contralateral sides to ligation
(F=91.46, P,0.0001). On the other hand, in the sham operated
group, there was no significant difference in mechanical thresholds
between the ipsilateral and the contralateral sides to operation
(Figure 1B; two-way RM ANOVA, ipsilateral vs. contralateral, P.
0.05).
When mice were supplied with hydrogen water for the whole
experimental period (from day 0 (right after PSNL operation) to
21), they exhibited a significant and long-lasting decrease in their
mechanical threshold on the ipsilateral side to ligation compared
with the contralateral side (Figure 1A; two-way RM ANOVA,
ipsilateral vs. contralateral, F=16.21, P,0.001), similar to mice
without hydrogen treatment. However, the hydrogen-treated mice
exhibited higher threshold on the ipsilateral side to ligation when
compared with mice without hydrogen treatment (Figure 1A). A
two-way RM ANOVA indicated a significant difference between
hydrogen-treated mice and controls (ipsilateral H2 (+) vs. ipsilateral
H2 (–), F=9.43, P,0.0046). In the sham-operated group with
hydrogen treatment, there was no significant difference in
mechanical thresholds between the ipsilateral and the contralateral
sides to operation (Figure 1B; two-way RM ANOVA, ipsilateral
vs. contralateral, P.0.05). These results indicate that hydrogen
treatment significantly alleviated mechanical allodynia caused by
PSNL.
In the plantar test, control mice exhibited significant reduction
of paw withdrawal latency only on the ipsilateral side to the
ligation compared with the contralateral side (Figure 2A). A two-
way RM ANOVA conformed this, indicating a significant
difference between the ipsilateral and the contralateral sides to
ligation (ipsilateral vs. contralateral, F=13.36, P=0.0014). On the
other hand, in the sham operated group, there was no significant
difference in paw withdrawal latency between the ipsilateral and
the contralateral sides to operation (Figure 2B; two-way RM
ANOVA, ipsilateral vs. contralateral, P.0.05).
When mice were supplied with hydrogen water for the whole
experimental period, they did not exhibit significant reduction in
paw withdrawal latency on the ipsilateral side to ligation compared
with the contralateral side (Figure 2A; two-way RM ANOVA,
ipsilateral vs. contralateral, P.0.05). Furthermore, paw withdraw-
al latency on the ipsilateral side of mice with hydrogen treatment
was significantly longer than that of mice without hydrogen
treatment (Figure 2A). A two-way RM ANOVA indicated a
significant difference between them (ipsilateral H2 (+) vs. ipsilateral
H2 (–), F=11.42, P=0.0027). In the sham-operated group with
hydrogen treatment, there was no significant difference in paw
withdrawal latency between the ipsilateral and the contralateral
sides to operation (Figure 2B; two-way RM ANOVA, ipsilateral
H2 (+) vs. contralateral H2 (+), P.0.05). These results indicate that
both mechanical allodynia and thermal hyperalgesia induced by
PSNL can be alleviated by drinking hydrogen water.
Hydrogen Treatment was Effective against the
Development Phase but not against the Maintenance
Phase of Mechanical Allodynia
In the Seltzer model, the time course of the pain responses
consists of two-phases. The pain responses in the von Frey and the
Figure 1. Hydrogen treatment suppressed mechanical allodynia in the PSNL model. Neuropathic mechanical allodynia was analysed by
the von Frey test. Hydrogen was supplied for the whole experimental period right after PSNL or sham operation. The control group received distilled
water from day 0 to 21. (A) The hydrogen-treated mice exhibited higher threshold on the ipsilateral side to ligation than controls (n = 12 mice for each
group). (B) Sham operation did not caused mechanical allodynia regardless of hydrogen treatment (n = 12 mice for each group). We used a two-way
RM ANOVA with a Bonferroni post-hoc test; *P,0.05, **P,0.01, ***P,0.001 vs. contralateral side of control mice, #P,0.05 vs. ipsilateral side of
control mice.
doi:10.1371/journal.pone.0100352.g001
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plantar test were gradually increased till 4 days after PSNL and
then followed by sustained pain behaviors as observed in figures 1
and 2. To examine the effect of hydrogen on the induction phase,
hydrogen was administered from day 0 to 4. The von Frey test
revealed that mice with hydrogen treatment exhibited a higher
threshold on the ipsilateral side when compared with that of mice
without hydrogen (Figure 3A). A two-way RM ANOVA indicated
a significant difference between hydrogen-treated mice and
controls (ipsilateral H2 (+) vs. ipsilateral H2 (–), F=9.06,
P=0.0064). These results indicate that hydrogen treatment was
effective on the development of mechanical allodynia. It is worth
noting that an analgesic effect lasted for the whole experiment
period even after the termination of hydrogen treatment
(Figure 3A).
When hydrogen was administered from day 4 to 21 (mainte-
nance phase), the von Frey test indicated that there was no
significant difference in mechanical thresholds on the ipsilateral
side to ligation between mice with hydrogen treatment and
controls (Figure 3B; two-way RM ANOVA, ipsilateral H2 (+) vs.
ipsilateral H2 (–), P.0.05). These results indicate that hydrogen
treatment is effective against the induction phase, but not against
the maintenance phase in mechanical allodynia.
Hydrogen Treatment was Effective against both
Induction and Maintenance Phases in Thermal
Hyperalgesia
The plantar test also revealed that hydrogen treatment
attenuated the induction of hyperalgesia. When hydrogen was
administered from day 0 to 4, these mice exhibited significantly
longer paw withdrawal latency on the ipsilateral side compared
with mice without hydrogen (Figure 4A; two-way RM ANOVA,
ipsilateral H2 (+) vs. ipsilateral H2 (–), F=6.66, P=0.017).
When mice were administered hydrogen water from day 4 to
21, they also exhibited significantly longer paw withdrawal latency
on the ipsilateral side compared with that in mice without
hydrogen (Figure 4B; two-way RM ANOVA, ipsilateral H2 (+) vs.
ipsilateral H2 (–), F=4.64, P=0.04). These results indicate that
hydrogen treatment is effective against both induction and
maintenance phases in thermal hyperalgesia.
Hydrogen Suppressed the Increase of Oxidative Stress in
the Spinal Cord Dorsal Horn and the DRG 4 days after
PSNL
To examine the effect of hydrogen water against oxidative
stress, we conducted immunohistochemical analysis using anti-
bodies against oxidative stress markers. We evaluated the numbers
of 4-HNE or 8-OHdG positive cells in the spinal cord (at the level
of L5) at the end of 4 days period after PSNL or sham operation.
The number of 4-HNE positive cells was increased in the spinal
cord dorsal horn from mice with PSNL (Figure 5A) compared with
the sham-operated controls (Figures 5C). However, the number of
positive cells was decreased in mice that received hydrogen water
from day 0 (right after PSNL operation) to 4 (Figures 5B)
compared with mice without hydrogen (Figures 5A). The
quantification confirmed this, indicating a significant difference
between them (Figure 5G; t test, H2 (–) vs. H2 (+), t = 2.33,
P=0.021). Similarly, the number of 8-OHdG positive cells was
increased in the spinal cord dorsal horn from mice with PSNL
(Figure 5D) compared with the sham-operated controls
(Figures 5F). The number of positive cells was decreased in mice
treated with hydrogen (Figures 5E) compared with mice without
hydrogen (Figures 5D). The quantification indicated a significant
difference between them (Figure 5H; t test, H2 (–) vs. H2 (+),
t = 1.83, P=0.049). These results indicate that drinking of
hydrogen water suppress the increase of oxidative stress induced
by PSNL in the spinal cord dorsal horn.
We also evaluated staining for 4-HNE and 8-OHdG in the
DRG (at the level of L5) at the end of 4 days period after PSNL.
Weak staining for 4-HNE was detected in mice with PSNL
(Figures 6A), but not from the sham-operated controls (Figures 6C).
Judging from the morphological appearance, 4-HNE was mainly
located in the membrane region of neuronal cells (Figures 6A).
Figure 2. Hydrogen treatment suppressed thermal hyperalgesia in the PSNL model. Thermal hyperalgesia was analysed by the plantar
test. The same sets of mice used for the von Frey test were used in the plantar test. (A) The reduction of paw withdrawal latency was attenuated in
mice with hydrogen compared with those without hydrogen (n = 12 mice for each group). (B) Sham operation did not cause hyperalgesia regardless
of hydrogen treatment (n = 12 mice for each group). We used a two-way RM ANOVA with a Bonferroni post-hoc test; *P,0.05 vs. contralateral side of
control mice, #P,0.05 vs. ipsilateral side of control mice.
doi:10.1371/journal.pone.0100352.g002
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Staining for 4-HNE was reduced in mice treated with hydrogen
(Figures 6B) compared with mice without hydrogen (Figures 6A).
The quantification indicated a significant difference between them
(Figure 6D; 4-HNE, t test, H2 (–) vs. H2 (+), t = 2.08, P=0.032).
These data indicate that drinking of hydrogen water suppress the
increase of 4-HNE induced by PSNL in the DRG. On the
contrary, the 8-OHdG positive cells were hardly detected in the
DRG from mice with PSNL as well as in those from the sham-
operated controls.
We further analyzed the properties of 4-HNE expression in the
spinal cord dorsal horn from mice with PSNL at the end of 4 days
period after ligation. 4-HNE was hardly detected in neuronal cells,
as indicated by double staining for 4-HNE and the neuronal
marker NeuN (Figure 7A). Similarly, double staining for 4-HNE
Figure 3. Hydrogen treatment was effective against the induction phase but not against the maintenance phase of mechanical
allodynia. (A) Hydrogen water was supplied from day 0 to 4, and after then changed to distilled water. Paw withdrawal threshold was significantly
lower in the H2 (+) group when compared with the H2 (–) group (n = 12 mice for each group). Note that the lower threshold in the H2 (+) group lasted
beyond the termination of hydrogen treatment. (B) Hydrogen water was supplied from day 4 to 21. There was no significant difference in paw
withdrawal threshold between the H2 (+) and the H2 (–) groups (n = 12 mice for each group). These experiments were performed concurrently with
those in Figure 1. We used a two-way RM ANOVA with a Bonferroni post-hoc test; *P,0.05, **P,0.01, ***P,0.001 vs. contralateral side of same mice.
#P,0.05 vs. ipsilateral side of H2 (–) mice.
doi:10.1371/journal.pone.0100352.g003
Figure 4. Hydrogen treatment was effective against both induction and maintenance phases of thermal hyperalgesia. (A) When
hydrogen water was supplied from day 0 to 4, paw withdrawal latency was longer in the H2 (+) group when compared with the H2 (–) group (n = 12
mice for each group). Note that the lower threshold in the H2 (+) group lasted beyond the termination of hydrogen treatment. (B) When hydrogen
water was supplied from day 4 to 21, there was a significant difference in paw withdrawal latency between the H2 (+) and the H2 (–) groups (n = 12
mice for each group). These experiments were performed concurrently with those in Figure 2. We used a two-way RM ANOVA with a Bonferroni post-
hoc test; *P,0.05 vs. contralateral side of same mice. #P,0.05 vs. ipsilateral side of H2 (–) mice.
doi:10.1371/journal.pone.0100352.g004
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and the astrocyte marker GFAP indicated that 4-HNE was not
expressed in astrocytes (Figure 7B). On the other hand, double
staining for 4-HNE and the oligodendrocyte marker NG2
indicated the expression of 4-HNE in oligodendrocyte
(Figure 7C). Furthermore, double staining for 4-HNE and another
oligodendrocyte marker Olig2 confirmed the expression of 4-HNE
in oligodendrocyte (Figure 7D). Double staining for 4-HNE and
the specific microglia marker Iba1 showed that 4-HNE was not
expressed in microglia (Figure 7E). These data indicate that 4-
HNE is expressed mainly in oligodendrocyte at the end of 4 days
period after PSNL.
Discussion
In this report, we show that hydrogen has a potent analgesic
effect against neuropathic pain. Our result is consistent with other
previous studies that reported the analgesic effects of ROS
scavengers against neuropathic pain. Systemic injection of PBN,
which is a non-specific ROS scavenger that scavenges all types of
ROS indiscriminately, relieved mechanical allodynia induced by
spinal nerve ligation in the rat [5]. Tal et al. reported that systemic
injection of TEMPOL reduced hyperalgesia induced by chronic
constriction injury in rats [7]. Kim et al. reported that systemic
injection of vitamin E attenuated mechanical allodynia and
thermal hyperalgesia caused by spinal nerve ligation in rodents
[8]. PBN and vitamin E were also effective in producing analgesia
by intrathecal injection, indicating that the spinal mechanism is, at
least in part, important in neuropathic pain [5,8]. On the other
hand, peripheral ROS also seem to be involved in the generation
of pain [1].
Figure 5. Hydrogen suppressed the development of oxidative stress in the spinal cord dorsal horn. (A–F) Representative images of
immunohistochemical staining for the oxidative stress markers 4-HNE (A–C) and 8-OHdG (D-F) in the spinal cord dorsal horn at the level of L5.
Staining for 4-HNE was increased in the spinal cord at the end of 4 days period after PSNL (A) compared with sham operation (C). (B) The number of 4-
HNE positive cells was decreased in mice with hydrogen when compared with the H2 (–) group (A). Similarly, staining for 8-OHdG was also increased
in the spinal cord from mice with PSNL (D) compared with sham operation (F). (E) The number of 8-OHdG positive cells was decreased in mice with
hydrogen at the end of 4 days period after PSNL when compared with the H2 (–) group (D). (G, H) The numbers of positive cells for both markers were
significantly decreased when compared with the H2 (–) group. *P,0.05 compared with control (t test, n = 6 mice for each). Scale bar: 200 mm.
doi:10.1371/journal.pone.0100352.g005
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We observed that hydrogen reduced oxidative stress caused by
PSNL in the spinal cord and the DRG, although little is known
about how oxidative stress contribute to neuropathic pain. In this
study, we used 4-HNE and 8-OHdG as biomarkers for oxidative
stress. 4-HNE is an aldehyde toxic end product of lipid
peroxidation and used as a biomarker for membrane lipid
peroxidation. 8-OHdG is an oxidized nucleoside accumulated in
both mitochondrial and nuclear DNA and used as a biomarker for
oxidative DNA damage. 4-HNE and 8-OHdG as well-known
biomarkers for oxidative insults caused by hydroxyl radical.
Because hydrogen selectively reduces hydroxyl radical [9], 4-HNE
and 8-OHdG are suitable for analysing anti-oxidative effect of
hydrogen [9–11,20]. In this relation, it was reported that 4-HNE
was significantly reduced by drinking hydrogen water in mouse
model of Parkinson’s disease, whereas intensity of dihydroethi-
dium, which was oxidized by superperoxide, was not significantly
reduced by hydrogen water [11].
Our results indicated that, in the spinal cord, 4-HNE was
located mainly in oligodendrocyte at the end of 4 days period after
PSNL. Oligodendrocyte is responsible for myelinisation in the
CNS and myelin ensheathes neuronal axons allowing fast nerve
conduction. Although less is known about the possible role of
oligodendrocyte in neuropathic pain, recent report suggests the
involvement of spinal oligodendrocyte in neuropathic pain. For
instance, spinal transportation of oligodendrocyte progenitor cells
reduced spinal cord injury-induced chronic neuropathic pain by
enhancing remyelination [21]. Further studies will be needed to to
understand the role of 4-HNE in oligodendrocyte for neuropathic
pain.
We observed the weak staining for 4-HNE in the DRG at the
end of 4 days period after PSNL, which was located in neuronal
cells. Staining for 8-OHdG was hardly detected in the DRG in
contrary to the spinal cord. Currently, we cannot know the reason
for the different expression pattern of markers for oxidative stress
between in the DRG and in the spinal cord. Further study is
required to understand the role of oxidative stress in the spinal
cord and the DRG to neuropathic pain.
We must emphasize that hydrogen was given orally in the
current study. Generally, administration of agents by oral
pathways is less effective than administration by intra-peritoneal
or intrathecal methods. Thus, the efficacy of oral administration is
very important from a clinical point of view because continuous
intra-peritoneal or intrathecal injections are intolerable. Molecular
hydrogen is electrically neutral and has a low molecular weight.
Thus, hydrogen readily passes through the blood brain barrier and
reaches target cells, unlike other antioxidants that have higher
molecular weights and/or polarized structures, making it difficult
to reach the target. These specific propensities of hydrogen may
contribute to its high efficacy in spite of oral administration.
Although we do not know the precise mechanism with which oral
hydrogen reduce the increase of oxidative stress after PSNL, oral
hydrogen may reach the target site very rapidly. For instance, it
was reported that hydrogen molecule can be delivered to the blood
in minutes in drinking hydrogen water [10]. It was also suggested
Figure 6. Hydrogen suppressed the development of oxidative stress in the DRG. (A–C) Representative images of immunohistochemical
staining for oxidative stress markers 4-HNE in the DRG at the level of L5. Weak staining for 4-HNE (arrows) was observed in the DRG from mice
without hydrogen at the end of 4 days period after PSNL (A), whereas staining for 4-HNE was not observed in sham operation mice (C). (B) Staining
for 4-HNE was reduced in mice with hydrogen at the end of 4 days period after PSNL. (D) The proportion of 4-HNE positive cells was significantly
decreased when compared with the H2 (–) group (A). Results are expressed as percent of total neurons. *P,0.05 compared with control (t test, n = 6
mice for each). Scale bar: 20 mm.
doi:10.1371/journal.pone.0100352.g006
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that hydrogen might reach the target site by gaseous diffusion,
which make it highly effective for reducing hydroxyl radicals [9].
Recently, it was reported that intrathecal administration of
hydrogen-rich saline relieve neuropathic pain induced by CCI in
rats [22]. This accord with our study and further support the
possibility of therapeutic use of hydrogen in pain medicine. Based
on the result of this report, anti-oxidant effect of hydrogen in the
spinal cord is, at least in part, important in alleviating neuropathic
pain. It would be helpful for extending hydrogen application if the
date from intraperitoneal injection, intravenous injection, and
intrathecal injection of hydrogen was collected as a supporting
evidence.
Recently, accumulating evidence suggests that hydrogen is a
highly effective antioxidant that has therapeutic potencies for some
diseases without remarkable side effects. For instance, hydrogen
can reportedly ameliorate reperfusion injury [23], atherosclerosis
[24], carcinogenesis [25], neurodegenerative disorders [26],
hearing disorders [27], and neuroapoptosis induced by neonatal
anesthesia [19] without serious harmful side effect. In addition,
hydrogen is already used in clinic for the prevention of
decompression sickness in divers [9].
It is important to identify which type of ROS is critically
involved in neuropathic pain; however, this is difficult because
most antioxidants can react with various ROS indiscriminately.
Our results indicate that hydroxyl radical has, at least in part, an
important role in both induction and maintenance of neuropathic
pain because hydrogen acts only with hydroxyl radical. However,
our results could not exclude the possibility that other ROS
contribute to neuropathic pain. It was reported that the inhibitors
of nitric oxide (NO) synthase reduced pain behaviors, indicating
that NO is involved in the mechanism of neuropathic pain [28]. In
addition, superoxide is also reportedly involved in the mechanism
of neuropathic pain since hyperalgesia was reduced by systemic
injection of TEMPOL, which removes one type of free radical, the
superoxide [7].
Interestingly, in mice that received hydrogen water from day 0
to 4, the analgesic effect continued even after the cessation of
drinking hydrogen water. Therefore, it seems likely that the
hydroxyl radical in the induction phase may be important to
develop neuropathic pain following PSNL. Furthermore, in mice
that received hydrogen water from day 4 to 21, thermal
hyperalgesia was gradually improved until day 21, although it
reached a maximum at day 4, indicating that the analgesic effect of
hydrogen water was also effective against established hyperalgesia.
Thus, it may be that hydroxyl radical contributes to maintenance
as well as induction of thermal hyperalgesia in the PSNL model. In
contrast to hyperalgesia, hydrogen did not improve mechanical
allodynia when given during day 4 to 21, indicating that the
analgesic effect of hydrogen water was not effective for established
mechanical allodynia. Although we do not know the reason for the
difference between allodynia and hyperalgesia in the maintenance
phase, it is intriguing to speculate that the pathomechanism of
mechanical allodynia and thermal hyperalgesia may be different
with regard to the vulnerability to oxidative stress in the
maintenance phase.
In conclusion, oral administration of water containing hydrogen
can be an effective and easy strategy for treating neuropathic pain.
Another study indicated that removal of excessive ROS could also
produce an analgesic effect against acute inflammatory pain [29].
Further studies will be needed to understand the effect of hydrogen
on other types of pain.
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